Current and historical daily PS Ratio for TECH (
Bio-Techne Corp
) from 1990 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Bio-Techne stock (TECH) PS ratio as of Jul 21 2026 is 9.27.
More Details
Bio-Techne Corp (TECH) PS Ratio Chart
Bio-Techne Corp (TECH) PS Ratio Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1207
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Bio-Techne PS Ratio Historical Data | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date | PS Ratio Data | Date | PS Ratio Data | ||||||
| 2026-07-21 | 9.3 | 9.29 | 9.26 | 9.29 | 2026-05-14 | 5.9 | 5.96 | 5.75 | 5.8 |
| 2026-07-20 | 9.3 | 9.33 | 9.27 | 9.28 | 2026-05-13 | 6.1 | 6.1 | 5.72 | 5.81 |
| 2026-07-17 | 9.3 | 9.34 | 9.26 | 9.34 | 2026-05-12 | 6.2 | 6.26 | 6.03 | 6.14 |
| 2026-07-16 | 9.3 | 9.3 | 9.26 | 9.3 | 2026-05-11 | 6.4 | 6.41 | 6.13 | 6.14 |
| 2026-07-15 | 9.3 | 9.26 | 9.24 | 9.26 | 2026-05-08 | 6.5 | 6.54 | 6.2 | 6.26 |
| 2026-07-14 | 9.2 | 9.26 | 9.21 | 9.23 | 2026-05-07 | 6.1 | 6.61 | 6.01 | 6.59 |
| 2026-07-13 | 9.2 | 9.26 | 9.21 | 9.24 | 2026-05-06 | 7.3 | 7.34 | 5.84 | 6.14 |
| 2026-07-10 | 9.2 | 9.25 | 9.18 | 9.24 | 2026-05-05 | 7.3 | 7.38 | 7.06 | 7.34 |
| 2026-07-09 | 9.2 | 9.22 | 9.17 | 9.22 | 2026-05-04 | 7.1 | 7.15 | 7 | 7.09 |
| 2026-07-08 | 9.2 | 9.19 | 9.13 | 9.19 | 2026-05-01 | 7.1 | 7.21 | 6.94 | 7.13 |
| 2026-07-07 | 9.2 | 9.19 | 9.14 | 9.15 | 2026-04-30 | 6.8 | 7.24 | 6.72 | 7.17 |
| 2026-07-06 | 9.2 | 9.19 | 9.15 | 9.19 | 2026-04-29 | 6.9 | 6.96 | 6.61 | 6.73 |
| 2026-07-02 | 9.2 | 9.2 | 9.15 | 9.17 | 2026-04-28 | 7.1 | 7.16 | 6.86 | 6.93 |
| 2026-07-01 | 9.2 | 9.2 | 9.14 | 9.2 | 2026-04-27 | 7.0 | 7.19 | 6.97 | 7.14 |
| 2026-06-30 | 9.2 | 9.19 | 9.14 | 9.15 | 2026-04-24 | 6.8 | 7.09 | 6.74 | 7.02 |
| 2026-06-29 | 9.2 | 9.21 | 9.16 | 9.18 | 2026-04-23 | 7.5 | 7.46 | 6.62 | 6.76 |
| 2026-06-26 | 9.2 | 9.23 | 9.15 | 9.2 | 2026-04-22 | 7.8 | 7.85 | 7.51 | 7.59 |
| 2026-06-25 | 9.1 | 9.19 | 9.08 | 9.16 | 2026-04-21 | 7.9 | 8.09 | 7.72 | 7.73 |
| 2026-06-24 | 7.4 | 7.81 | 7.36 | 7.63 | 2026-04-20 | 7.7 | 7.89 | 7.59 | 7.85 |
| 2026-06-23 | 7.2 | 7.42 | 7.22 | 7.29 | 2026-04-17 | 7.6 | 7.77 | 7.55 | 7.67 |
| 2026-06-22 | 7.5 | 7.59 | 7.18 | 7.2 | 2026-04-16 | 7.5 | 7.57 | 7.36 | 7.43 |
| 2026-06-18 | 7.2 | 7.55 | 7.14 | 7.51 | 2026-04-15 | 7.7 | 7.74 | 7.52 | 7.58 |
| 2026-06-17 | 7.2 | 7.43 | 7.04 | 7.12 | 2026-04-14 | 7.5 | 7.83 | 7.47 | 7.6 |
| 2026-06-16 | 7.3 | 7.38 | 7.19 | 7.26 | 2026-04-13 | 7.2 | 7.47 | 7.16 | 7.45 |
| 2026-06-15 | 7.2 | 7.32 | 7.08 | 7.28 | 2026-04-10 | 7.2 | 7.27 | 7.13 | 7.19 |
| 2026-06-12 | 7.0 | 7.07 | 6.9 | 6.99 | 2026-04-09 | 7.1 | 7.28 | 6.92 | 7.2 |
| 2026-06-11 | 6.8 | 7.01 | 6.73 | 7 | 2026-04-08 | 7.2 | 7.37 | 6.98 | 7.15 |
| 2026-06-10 | 7.0 | 7.09 | 6.77 | 6.8 | 2026-04-07 | 6.8 | 7.03 | 6.81 | 6.97 |
| 2026-06-09 | 6.9 | 7.15 | 6.89 | 7.05 | 2026-04-06 | 6.9 | 6.98 | 6.73 | 6.97 |
| 2026-06-08 | 6.8 | 6.94 | 6.73 | 6.82 | 2026-04-02 | 6.7 | 7.1 | 6.64 | 6.88 |
| 2026-06-05 | 6.9 | 6.89 | 6.64 | 6.73 | 2026-04-01 | 6.8 | 7.01 | 6.77 | 6.93 |
| 2026-06-04 | 6.7 | 6.9 | 6.65 | 6.89 | 2026-03-31 | 6.8 | 6.89 | 6.63 | 6.77 |
| 2026-06-03 | 6.4 | 6.59 | 6.35 | 6.59 | 2026-03-30 | 6.7 | 6.78 | 6.62 | 6.74 |
| 2026-06-02 | 6.5 | 6.53 | 6.38 | 6.45 | 2026-03-27 | 6.8 | 6.93 | 6.54 | 6.59 |
| 2026-06-01 | 6.7 | 6.71 | 6.56 | 6.58 | 2026-03-26 | 6.8 | 6.94 | 6.75 | 6.82 |
| 2026-05-29 | 6.6 | 6.75 | 6.53 | 6.7 | 2026-03-25 | 6.8 | 6.89 | 6.73 | 6.82 |
| 2026-05-28 | 6.3 | 6.63 | 6.22 | 6.59 | 2026-03-24 | 6.7 | 6.85 | 6.56 | 6.78 |
| 2026-05-27 | 6.3 | 6.4 | 6.12 | 6.23 | 2026-03-23 | 6.8 | 6.92 | 6.68 | 6.73 |
| 2026-05-26 | 6.2 | 6.3 | 6.09 | 6.21 | 2026-03-20 | 6.7 | 6.75 | 6.56 | 6.66 |
| 2026-05-22 | 6.1 | 6.25 | 6.1 | 6.24 | 2026-03-19 | 6.5 | 6.77 | 6.47 | 6.67 |
| 2026-05-21 | 6.0 | 6.14 | 5.87 | 6.14 | 2026-03-18 | 6.5 | 6.64 | 6.41 | 6.57 |
| 2026-05-20 | 5.9 | 6.06 | 5.73 | 6.05 | 2026-03-17 | 6.4 | 6.63 | 6.4 | 6.61 |
| 2026-05-19 | 5.8 | 6.03 | 5.79 | 5.89 | 2026-03-16 | 6.7 | 6.76 | 6.24 | 6.31 |
| 2026-05-18 | 5.7 | 5.85 | 5.6 | 5.76 | 2026-03-13 | 6.8 | 6.8 | 6.55 | 6.58 |
| 2026-05-15 | 5.8 | 5.91 | 5.6 | 5.61 | 2026-03-12 | 6.8 | 6.99 | 6.45 | 6.66 |
Bio-Techne Corp (TECH) PS Ratio Comparison
| Company | Market Cap(Mil) | PS Ratio |
|---|
Business Description
Business Description
Bio-Techne Corp
NAICS : 325414
SIC : 2836
ISIN : US09073M1045
Share Class Description:
TECH: Ordinary SharesTotal Employee Number:
3,100Compare
Compare
Traded in other countries / regions
TECH.USATE1.GermanyT1CH34.Brazil1TECH.ItalyTECH.Mexico Index Membership
S&P 500Russell 1000Russell 3000 IPO Date
1989-05-08Description
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers